BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16394141)

  • 1. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
    Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
    Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology.
    Marquez VE; Barchi JJ; Kelley JA; Rao KV; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):305-18. PubMed ID: 16247946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebularine: a candidate for epigenetic cancer therapy.
    Bradbury J
    Drug Discov Today; 2004 Nov; 9(21):906-7. PubMed ID: 15501719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo.
    Tan W; Zhou W; Yu HG; Luo HS; Shen L
    Biochem Biophys Res Commun; 2013 Jan; 430(1):250-5. PubMed ID: 23167995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
    Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine).
    Jeong LS; Buenger G; McCormack JJ; Cooney DA; Hao Z; Marquez VE
    J Med Chem; 1998 Jul; 41(14):2572-8. PubMed ID: 9651161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
    Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
    J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.
    Ruan H; Qiu S; Beard BC; Black ME
    Protein Eng Des Sel; 2016 Dec; 29(12):573-582. PubMed ID: 27160178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
    Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
    Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
    Gnyszka A; Jastrzebski Z; Flis S
    Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of zebularine from its 2'-deoxyribonucleoside triphosphate derivative and activity as a template-coding nucleobase.
    Dowd CL; Sutch BT; Haworth IS; Eritja R; Marquez VE; Yang AS
    Nucleosides Nucleotides Nucleic Acids; 2008 Feb; 27(2):131-45. PubMed ID: 18205068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential response of cancer cells to zebularine.
    Cheng JC; Yoo CB; Weisenberger DJ; Chuang J; Wozniak C; Liang G; Marquez VE; Greer S; Orntoft TF; Thykjaer T; Jones PA
    Cancer Cell; 2004 Aug; 6(2):151-8. PubMed ID: 15324698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer prevention: epigenetics steps up to the plate.
    Issa JP
    Cancer Prev Res (Phila); 2008 Sep; 1(4):219-22. PubMed ID: 19138962
    [No Abstract]   [Full Text] [Related]  

  • 16. The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.
    Herranz M; Martín-Caballero J; Fraga MF; Ruiz-Cabello J; Flores JM; Desco M; Marquez V; Esteller M
    Blood; 2006 Feb; 107(3):1174-7. PubMed ID: 16239434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.
    Zauri M; Berridge G; Thézénas ML; Pugh KM; Goldin R; Kessler BM; Kriaucionis S
    Nature; 2015 Aug; 524(7563):114-8. PubMed ID: 26200337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
    Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
    Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain.
    Marquez VE; Eritja R; Kelley JA; Vanbemmel D; Christman JK
    Ann N Y Acad Sci; 2003 Dec; 1002():154-64. PubMed ID: 14751833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology: Salvaging the genome.
    Sivanand S; Wellen KE
    Nature; 2015 Aug; 524(7563):40-1. PubMed ID: 26200344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.